Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Revenue increased 1.3% YoY to JPY148.2bn, while operating profit declined 34.5% YoY to JPY806mn.</li><li>Pharmaceutical Wholesale business revenue rose 1.1% YoY, but segment profit decreased 7.3% YoY due to higher SG&A expenses.</li><li>Pharmacy business revenue decreased 0.2% YoY, yet segment profit increased 27.3% YoY from dispensing fees.</li></ul>

Revenue increased 1.3% YoY to JPY148.2bn, while operating profit declined 34.5% YoY to JPY806mn.Pharmaceutical Wholesale business revenue rose 1.1% YoY, but segment profit decreased 7.3% YoY due to higher SG&A expenses.Pharmacy business revenue decreased 0.2% YoY, yet segment profit increased 27.3% YoY from dispensing fees.

Vital Ksk Holdings (3151 JP): Q1 FY03/26 flash update

<ul><li>Revenue increased by 2.2% YoY to JPY600.4bn, driven by higher sales of anticancer drugs and vaccines.</li><li>Operating profit rose 2.7% YoY to JPY5.7bn, supported by increased revenue and price negotiations offsetting higher business investment expenses.</li><li>For FY03/26, the company forecasts revenue of JPY620.0bn, with a focus on unapproved drug introduction and strategic shareholding disposal.</li></ul>

Revenue increased by 2.2% YoY to JPY600.4bn, driven by higher sales of anticancer drugs and vaccines.Operating profit rose 2.7% YoY to JPY5.7bn, supported by increased revenue and price negotiations offsetting higher business investment expenses.For FY03/26, the company forecasts revenue of JPY620.0bn, with a focus on unapproved drug introduction and strategic shareholding disposal.

Vital Ksk Holdings (3151 JP): Full-year FY03/25 flash update

Japan

VITAL KSK HOLDINGS Inc. is a holding company and provides pharmaceutical sales. The Company manufactures and wholesales pharmaceuticals to hospitals and drugstores.  VITAL KSK HOLDINGS also provides property & casualty insurance services and elderly care services through its subsidiaries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vital Ksk Holdings (3151 JP)